FSXLF yields 596.57% · PFE yields 6.13%● Live data
📍 FSXLF pulled ahead of the other in Year 1
Combined, FSXLF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of FSXLF + PFE for your $10,000?
Great Pacific Gold Corp., a junior exploration company, engages in the acquisition, exploration, and development of mineral properties in Australia and Papua New Guinea. It primarily explores for copper and gold deposits. The company's flagship projects include the Wild Dog project comprising two granted exploration licenses covering an area of 1422 square kilometers located in the island of New Britain, Papua New Guinea; and the Kesar Creek project which comprises one granted exploration license covering an area of 130 square kilometers, as well as the Arau project which consists of two granted exploration licenses covering approximately 614 square kilometers both located in the Kainantu region, Eastern Highlands Province, Papua New Guinea. The company was formerly known as Fosterville South Exploration Ltd. and changed its name to Great Pacific Gold Corp. in September 2023. Great Pacific Gold Corp. was incorporated in 2019 and is headquartered in Vancouver, Canada.
Full FSXLF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.